This topic contains a solution. Click here to go to the answer

Author Question: According to the most recent research, which of the following statements is true concerning ethnic ... (Read 56 times)

gbarreiro

  • Hero Member
  • *****
  • Posts: 566
According to the most recent research, which of the following statements is true concerning ethnic background and the development of Alzheimer's disease of dementia?
 
  a. Japanese, Nigerian, and Amish have lower rate of prevalence of the disorder.
 b. Alzheimer's disease is found in roughly the same numbers across all ethnic groups.
  c. Educated European ethnic groups have a lower rate of getting the disease.
 d. Native Americans have a slightly higher rate of the disorder.

Question 2

Symptoms of Alzheimer's disease neurocognitive disorder typically appear between the ages of
 
  a. 40 and 50.
  b. 50 and 60.
  c. 60 and 70.
  d. 70 and 80.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Li Jun

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

b

Answer to Question 2

c




gbarreiro

  • Member
  • Posts: 566
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


aliotak

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Excellent

 

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library